Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio | N/A |
| Overall | INSUFFICIENT DATA |
$2.0B
5.46
0.454
8
$302.0K
7.12
0.1%
61
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($57.00, 8 analysts) | |||
| 10 | $414.10 | +$155.90 (38%) | 2.5R |
| 50 | $2,070.50 | +$779.50 (38%) | 2.5R |
| 100 | $4,141.00 | +$1,559.00 (38%) | 2.5R |
- Elevated short interest (7.12 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| APGE | 0.402 |
| IWM | 0.383 |
| XNCR | 0.381 |
| CLDX | 0.372 |
| NRIX | 0.364 |
| Ticker | Correlation |
|---|---|
| ABC.BH | -0.164 |
| CME | -0.139 |
| ABF.L | -0.126 |
| CBOE | -0.125 |
| ABQK.QA | -0.116 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.